Comerica Bank
RCUS icon

Comerica Bank’s Arcus Biosciences RCUS Stock Holding History

Comerica Bank’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$455K Sell
19,109
-383
-2% -$7.81K ﹤0.01% 1906
2025
Q3 		$265K Sell
19,492
-3,670
-16% -$38.2K ﹤0.01% 2211
2025
Q2 		$189K Sell
23,162
-136
-0.6% -$1.16K ﹤0.01% 2346
2025
Q1 		$183K Buy
23,298
+4,684
+25% +$54.3K ﹤0.01% 2338
2024
Q4 		$277K Buy
18,614
+11
+0.1% +$180 ﹤0.01% 2168
2024
Q3 		$284K Sell
18,603
-1,218
-6% -$19.2K ﹤0.01% 2146
2024
Q2 		$302K Sell
19,821
-2,578
-12% -$41.6K ﹤0.01% 2070
2024
Q1 		$423K Sell
22,399
-2,754
-11% -$47.6K ﹤0.01% 1953
2023
Q4 		$480K Buy
25,153
+531
+2% +$8.49K ﹤0.01% 1873
2023
Q3 		$442K Buy
24,622
+23,781
+2,828% +$478K ﹤0.01% 1851
2023
Q2 		$0 Buy
+841
New +$16K ﹤0.01% 909
2022
Q4 		$630K Sell
31,015
-8,680
-22% -$239K ﹤0.01% 1679
2022
Q3 		$1.1M Buy
39,695
+230
+0.6% +$6.08K 0.01% 1416
2022
Q2 		$1.13M Buy
+39,465
New +$966K 0.01% 1457

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Comerica Bank's RCUS Position: Q4 2025 in Review

Comerica Bank reduced its Arcus Biosciences (RCUS) stake by 2% in Q4 2025, selling an estimated $7.81K and leaving 19,109 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #1906.

Comerica Bank first reported a position in RCUS in Q2 2022 and has held it in 14 quarters since. The position peaked at $1.13M in Q2 2022. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.

  • Comerica Bank held 19,109 shares of Arcus Biosciences worth $455K as of Q4 2025.
  • Comerica Bank sold 383 Arcus Biosciences shares in Q4 2025, an estimated $7.81K.
  • Arcus Biosciences made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #1906 holding.
  • Comerica Bank first reported a position in Arcus Biosciences in Q2 2022 and has held it in 14 quarters since.
  • Comerica Bank's Arcus Biosciences position peaked at $1.13M in Q2 2022.
  • 209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.